SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001338095-17-000027
Filing Date
2017-05-24
Accepted
2017-05-24 13:10:13
Documents
15
Period of Report
2017-05-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrx8-kmay2017mor_05242017.htm 8-K 35546
2 EXHIBIT 99.1 di441maymor.htm EX-99.1 3822
3 di441maymor001.jpg GRAPHIC 92887
4 di441maymor002.jpg GRAPHIC 25848
5 di441maymor003.jpg GRAPHIC 14398
6 di441maymor004.jpg GRAPHIC 131862
7 di441maymor005.jpg GRAPHIC 214885
8 di441maymor006.jpg GRAPHIC 135406
9 di441maymor007.jpg GRAPHIC 73295
10 di441maymor008.jpg GRAPHIC 126611
11 di441maymor009.jpg GRAPHIC 167882
12 di441maymor010.jpg GRAPHIC 159230
13 di441maymor011.jpg GRAPHIC 74635
14 di441maymor012.jpg GRAPHIC 89004
15 di441maymor013.jpg GRAPHIC 125394
  Complete submission text file 0001338095-17-000027.txt   1990168
Mailing Address P.O. BOX 400 JAMISON PA 18929
Business Address P.O. BOX 400 JAMISON PA 18929 6095538887
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36303 | Film No.: 17866106
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences